← Back to Analyst Consensus 
ACIU Buy
AC Immune SA
Current Price —
Implied Upside —
Analysts 10
30-Day Momentum
▲ 0 upgrades / ▼ 0 downgrades / 0 reiterations from 0 firms
Next Earnings
Nov 10, 2026 (14 days)
Rating Timeline
| Date ▼ | Firm | Action | From → To Rating | Price Target | Firm Rating |
|---|---|---|---|---|---|
| Sep 23, 2026 | BTIG | reiterate | Buy → Buy | — | 52% |
| Aug 20, 2026 | BTIG | reiterate | Buy → Buy | — | 52% |
| Aug 5, 2026 | BTIG | reiterate | Buy → Buy | — | 52% |
| May 4, 2026 | BTIG | reiterate | Buy → Buy | — | 52% |
| Mar 16, 2026 | BTIG | reiterate | Buy → Buy | — | 52% |
| Nov 4, 2025 | BTIG | reiterate | Buy → Buy | $8 | 52% |
| Sep 8, 2025 | BTIG | reiterate | Buy → Buy | $8 | 52% |
| May 1, 2025 | HC Wainwright & Co. | maintain | Buy → Buy | $12 | 44% |
| Apr 3, 2025 | HC Wainwright & Co. | reiterate | Buy → Buy | $16 | 44% |
| Mar 14, 2025 | HC Wainwright & Co. | reiterate | Buy → Buy | $16 | 44% |
| Nov 15, 2024 | HC Wainwright & Co. | reiterate | Buy → Buy | $16 | 44% |
| Nov 6, 2024 | HC Wainwright & Co. | reiterate | Buy → Buy | $16 | 44% |
| Sep 18, 2024 | HC Wainwright & Co. | reiterate | Buy → Buy | $16 | 44% |
| May 31, 2024 | BTIG | initiate | — → Buy | $8 | 52% |
| Mar 15, 2024 | HC Wainwright & Co. | reiterate | Buy → Buy | $16 | 44% |
| Nov 13, 2023 | HC Wainwright & Co. | reiterate | Buy → Buy | $16 | 44% |
| Aug 7, 2023 | HC Wainwright & Co. | reiterate | Buy → Buy | $16 | 44% |
| Jun 28, 2023 | HC Wainwright & Co. | reiterate | Buy → Buy | $16 | 44% |
| May 1, 2023 | HC Wainwright & Co. | reiterate | — → Buy | $16 | 44% |
| Apr 19, 2023 | HC Wainwright & Co. | reiterate | — → Buy | $16 | 44% |
| Mar 17, 2023 | HC Wainwright & Co. | reiterate | — → Buy | $16 | 44% |
| Jul 11, 2022 | SVB Leerink | maintain | — → Outperform | $10 | — |
| Dec 20, 2021 | SVB Leerink | maintain | — → Outperform | $15 | — |
| Mar 24, 2021 | HC Wainwright & Co. | maintain | — → Buy | $16 | 44% |
| Dec 10, 2019 | HC Wainwright & Co. | reiterate | — → Buy | $11 | 44% |
| Feb 1, 2019 | UBS | downgrade | Buy → Neutral | $0 | 54% |
| Nov 13, 2018 | Leerink Swann | initiate | — → Outperform | $18 | — |
| Apr 5, 2018 | HC Wainwright & Co. | initiate | — → Buy | $18 | 44% |
| Oct 18, 2016 | Leerink Swann | initiate | — → Outperform | $0 | — |
Price Target Trend
Apr 1, 2026 Oct 27, 2026
EPS Estimates
+1y —
0y —
+1q —
0q —
Cross-Platform Signals
No cross-platform signals in the last 90 days